Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Trypanosoma Cruzi (T. cruzi)
100%
Drug Discovery
81%
Chagas Disease
57%
Trypanosoma
49%
Leishmania Donovani
47%
Visceral Leishmaniasis
43%
Molecular Targets
42%
Drug Target
37%
Trypanosoma Brucei
35%
African Trypanosomes
34%
Dundee
31%
Plasmodium Falciparum
31%
Preclinical Candidate
30%
LysR Family
28%
Cryptosporidium
27%
Malaria
27%
Wellcome
27%
Leishmania
26%
Infectious Diseases
25%
Protease Inhibitors
25%
Anti-infective
24%
Phenotypic Screening
23%
New Drugs
22%
L. Donovani
22%
Public Engagement
21%
T. Brucei
21%
Mechanism of Action
21%
Benzoxaborole
21%
Thermal Proteome Profiling
21%
RapidFire Mass Spectrometry
20%
Structure-activity Relationship
20%
Leucyl Aminopeptidase
20%
Protozoan Parasites
19%
Trypanocidal Activity
19%
High-throughput Screening Assays
19%
Mass Spectrometry
19%
Plasmodium
19%
Mode of Action Studies
19%
Spike Glycoprotein
18%
Antileishmanial
17%
Mouse Model
17%
Drug Development
17%
Cytochrome b
17%
Alternative Polyadenylation
17%
Leishmania Major
16%
Drug Resistance
16%
Human African Trypanosomiasis
16%
Antimalarial Drug Discovery
16%
Pull-down
16%
Fragment Molecular Orbital Method
16%
Clinical Development
16%
Small Molecules
15%
Putative Drug Targets
15%
Covalent Inhibitor
15%
Bloodstream Form
15%
Current Treatment
14%
Cas9 Protein
14%
Mode of Action
14%
Target Engagement
14%
Prodrug
14%
Antitrypanosomal Activity
14%
Metabolism
14%
Chagas Disease Drug Discovery
13%
Drug Discovery Program
13%
Specificity Factor
13%
Neglected Tropical Diseases
13%
Population Differentiation
13%
Population Heterogeneity
13%
Parasite Population
13%
Cell Atlas
13%
Veterinary
13%
Murals
13%
Guanine
13%
Chronic Chagas Disease
13%
Training Engagement
13%
Cysteine
13%
Kinetoplastid
13%
Oligo
13%
Research Participation
13%
Ghana
13%
Drug Metabolism
13%
Late-stage Functionalization
13%
Causative Agents
13%
High-throughput Screening
13%
Research Training
13%
Antileishmanial Compounds
11%
Aquaporin-2 (AQP2)
10%
Pharmacokinetics
10%
Commercially Available
10%
Protein Targeting
10%
Resistance mutations
10%
Specific Inhibitor
10%
Rapid Assessment
10%
Further Development
10%
Active Sites
9%
Chymotrypsin
9%
African Trypanosomiasis
9%
Resistance Profiling
9%
Triage
9%
Biologically Relevant
9%
Scoring Function
9%
Disease Areas
9%
Neglected Infectious Diseases
9%
EC50
9%
Compound Optimization
9%
Cross-resistance
9%
Medicinal Chemistry
9%
New Medicines
9%
Drug pipeline
9%
Quantum Mechanics
9%
C. Parvum
9%
Treatment Options
9%
High-throughput
9%
Recombinant
9%
Neglected Diseases
8%
Low-middle Income Countries
8%
Short Course
8%
Electron Transport Chain
8%
N7-methyltransferase
8%
Proteasome Inhibition
8%
Pyrrolopyrimidine
8%
Cytochrome bc1 Complex
8%
Binding Affinity
8%
Mycobacterium Tuberculosis (M. tb)
8%
Selective Inhibitor
8%
RapidFire
8%
Pharmacokinetic Properties
8%
Biological Data
8%
Screening Library
8%
PIC50
8%
Genetic Diversity
8%
Chemical Synthesis
8%
DNA Replication
7%
CYP51
7%
C. Hominis
7%
Cryptosporidium Species
7%
Mortality Rate
7%
Glycoprotein Gene
7%
Parasitic Diseases
7%
Transcriptome
7%
Unbiased Approach
7%
Cryptosporidiosis
7%
Kinetoplastid Parasites
7%
Benznidazole
7%
Binding Residues
7%
In Vivo Efficacy
7%
Oocyst
7%
Potent Inhibitor
7%
Drug Candidates
7%
Mouse Infection
7%
Knockdown
6%
Resistance Factor
6%
Oxidosqualene Cyclase
6%
Cell-free Lysate
6%
Antichagasic Activity
6%
Tropical Infectious Diseases
6%
Target Cleavage
6%
Antibiotic Drug Development
6%
Bias Control
6%
Oxaboroles
6%
Non-structural Protein 14
6%
Faba
6%
Compound 8
6%
Resistance Mapping
6%
Engagement Strategies
6%
Economic Burden
6%
Protein Synthesis
6%
Kinetic Characterization
6%
Anti-trypanosomatid Drugs
6%
Selection Marker
6%
Apicomplexan
6%
Codon Usage Bias
6%
Gluconeogenesis
6%
Glycerol
6%
Lysate
6%
Regulon
6%
RNA Interference Screen
6%
Tropical Diseases
6%
Development Needs
6%
Expression in Escherichia Coli
6%
Structure-based Design
6%
Poor People
6%
Recombination
6%
Global Health
6%
Carboxypeptidase
6%
Pyridazinone
6%
Chemical Diversity
6%
Protein Abundance
6%
Barcoded Library
6%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
6%
Methyltransferase
6%
Screening Kits
6%
Exhibition Space
6%
School-age children
6%
Synthetic Chemistry
6%
Protein-ligand Binding
6%
Probe-based
6%
Subsequent Events
6%
Hopping Strategy
6%
4-dione
6%
Immunology and Microbiology
Parasite
85%
Trypanosoma Cruzi
69%
Chagas Disease
51%
Visceral Leishmaniasis
47%
Infectious Disease
44%
Proteasome
41%
Infection
41%
Leishmania donovani
40%
Transfer RNA
35%
Cryptosporidium
32%
Trypanosoma
31%
Drug Resistance
25%
Mouse Model
22%
In Vitro
20%
Protozoa
20%
High Throughput Screening
19%
Mass Spectrometry
19%
Trypanosoma Brucei
17%
Polyadenylation
17%
Trypanosomatid
16%
Kinetoplastida
15%
Antimalarial Agent
15%
Plasmodium falciparum
15%
Malaria
15%
Wild Type
14%
Life Cycle
14%
Leishmania
14%
CRISPR/Cas9
13%
Drug Metabolism
13%
Cytochrome P450
11%
Plasmodium
11%
Infectious Agent
11%
Amino Acid
10%
Cytochrome
10%
Mutagenesis
10%
Cross-Resistance
9%
Oocyst
9%
Whole Genome Sequencing
9%
Neglected Disease
8%
Transcriptomics
8%
Trypomastigote
8%
Codon
8%
Cosmid
8%
Promastigote
8%
Antimicrobial Agent
8%
Wild Type Mouse
8%
Structure Activity Relation
8%
Protein Degradation
8%
Chromosome
8%
Parasitic Disease
8%
Susceptibility
8%
Binding Site
7%
Respiratory Chain
7%
Epimastigote
7%
Species Difference
7%
Genetic Variability
7%
Amastigote
7%
Ribonucleic Acid
6%
Aminopeptidase
6%
Sterol Synthesis
6%
Trans-Splicing
6%
Gluconeogenesis
6%
Intracellular Parasite
6%
Apicomplexa
6%
Drug Sensitivity
6%
Clustered Regularly Interspaced Short Palindromic Repeat
6%
Gene Amplification
6%
Enantiomer
6%
Trypanosoma Congolense
6%
DNA Damage
6%
Gene Editing
6%
Metabolite
6%
DNA Synthesis
6%
RNAI
6%
Phylogenomics
6%
Glycerol
6%
Serine
6%
Cysteine
6%
Codon Usage Bias
6%
Oligomerization
6%
Parasite Transmission
6%
Plasmodium berghei
6%
Luminescence
6%
Coronavirus
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Sterol
6%
Transcriptome
6%
Morbidity
6%
Pharmacokinetics
6%
Cryo-Electron Microscopy
5%
Genetic Transfection
5%
Chemotype
5%
DNA Template
5%
Real-Time Polymerase Chain Reaction
5%
Biochemistry, Genetics and Molecular Biology
Drug Development
49%
Parasite
44%
Trypanosoma Cruzi
30%
Trypanosoma
25%
Transfer RNA
22%
Enzyme
21%
Plasmodium falciparum
19%
Cryptosporidium
19%
Proteasome
19%
Trypanosoma Brucei
18%
Binding Site
17%
Mass Spectrometry
16%
Cytochrome B
15%
Trypanosomatidae
15%
Glycoprotein
15%
Infectious Agent
15%
Life Cycle
14%
Cleavage and Polyadenylation Specificity Factor
14%
Leishmania donovani
14%
Small Molecule
14%
Proteome
13%
High Throughput Screening
13%
Drug Resistance
12%
Protein Ligand
10%
Electron Transport Chain
9%
Messenger RNA
9%
Plasmodium
9%
Amino Acids
9%
Proteasome Inhibitor
9%
Epimastigote
8%
Transcriptomics
8%
Trypomastigote
8%
Quantum Theory
8%
Transcriptome
8%
Wild Type
8%
Leishmania
8%
Genetics
8%
Methyltransferase
7%
Endonuclease
7%
RNA
7%
Oocyst
7%
Metabolomics
7%
Transcription
7%
Ligand Binding
7%
CRISPR/Cas9
6%
Adenosine Triphosphate
6%
Chymotrypsin
6%
Mutagenesis
6%
Sterol
6%
Acetyl-CoA
6%
Entropy
6%
Luminescence
6%
Lanosterol 14 Alpha-Demethylase
6%
Regulon
6%
Gluconeogenesis
6%
Cyclase
6%
Cell Lysate
6%
Apicomplexa
6%
Conformation
6%
Essential Gene
6%
Oligomerization
6%
Leishmania Major
6%
Biological Target
6%
Retention Time
6%
Parasite Transmission
6%
Epigenetic Inheritance
6%
Dynamin
6%
Copurification
6%
Glycerol
6%
Untranslated Region
6%
Parasite Load
6%
Cytochrome P450 Reductase
6%
Codon Usage Bias
6%
Global Health
6%
CRISPR
6%
RNAI
6%
Reconstruction
6%
Cysteine
6%
Phylogenomics
6%
Escherichia coli
6%
Genetic Divergence
6%
Chemogenomics
6%
Aminopeptidase
6%
Guanine
6%
Mycobacterium Tuberculosis
6%
Codon
5%